Cordelia Ihl (C Salomez-Ihl)

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Respiratory Syndrome Coronavirus

Pulmonary Arterial Hypertension

Top Venues

Antimicrobial agents and chemotherapy

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Cordelia Ihl, J Giai, M Barbado, A Paris, S Touati, J P Alcaraz, S Tanguy, C Leroy, A Lehmann, B Degano, M Gavard, P Bedouch, P Pavese, A Moreau-Gaudry, M Roustit, François Boucher, P Cinquin, J P Brion
H 2 inhalation therapy in patients with moderate COVID-19 (H 2 COVID): a prospective ascending-dose phase I clinical trial. Antimicrobial agents and chemotherapy 68 (8) (2024)
Cordelia Ihl, J Giai, M Barbado, A Paris, S Touati, J P Alcaraz, S Tanguy, C Leroy, A Lehmann, B Degano, M Gavard, P Bedouch, P Pavese, A Moreau-Gaudry, M Roustit, François Boucher, P Cinquin, J P Brion
H 2 inhalation therapy in patients with moderate COVID-19 (H 2 COVID): a prospective ascending-dose phase I clinical trial. Antimicrobial agents and chemotherapy (2024)
Yoann Gaboreau, Aleksandra Milovančev, Carole Rolland, Claire Eychenne, Jean-Pierre Alcaraz, Cordelia Ihl, Roseline Mazet, François Boucher, Celine Vermorel, Sergej M. Ostojic, Jean-Christian Borel, Philippe Cinquin, Jean-Luc Bosson
Molecular Hydrogen for Outpatients with COVID-19 (Hydro-COVID): A Phase 3 Randomised, Triple-Blinded, Pragmatic, Placebo-Controlled, Multicentre Trial. Journal of clinical medicine 13 (15) (2024)
Yoann Gaboreau, Aleksandra Milovančev, Carole Rolland, Claire Eychenne, Jean-Pierre Alcaraz, Cordelia Ihl, Roseline Mazet, François Boucher, Celine Vermorel, Sergej M. Ostojic, Jean-Christian Borel, Philippe Cinquin, Jean-Luc Bosson
Molecular Hydrogen for Outpatients with COVID-19 (Hydro-COVID): A Phase 3 Randomised, Triple-Blinded, Pragmatic, Placebo-Controlled, Multicentre Trial. Journal of clinical medicine 13 (15) (2024)
Cordelia Ihl, J Giai, M Barbado, A Paris, S Touati, J P Alcaraz, S Tanguy, C Leroy, A Lehmann, B Degano, M Gavard, P Bedouch, P Pavese, A Moreau-Gaudry, M Roustit, François Boucher, P Cinquin, J P Brion
H 2 inhalation therapy in patients with moderate COVID-19 (H 2 COVID): a prospective ascending-dose phase I clinical trial. Antimicrobial agents and chemotherapy 68 (8) (2024)
Cordelia Ihl, J Giai, M Barbado, A Paris, S Touati, J P Alcaraz, S Tanguy, C Leroy, A Lehmann, B Degano, M Gavard, P Bedouch, P Pavese, A Moreau-Gaudry, M Roustit, François Boucher, P Cinquin, J P Brion
H 2 inhalation therapy in patients with moderate COVID-19 (H 2 COVID): a prospective ascending-dose phase I clinical trial. Antimicrobial agents and chemotherapy 68 (8) (2024)